Dyne Therapeutics Inc
DYN · NASDAQ
Dyne Therapeutics, Inc. operates as a biotechnology company. The Company focuses on transforming the lives of people with serious diseases by developing muscle-targeted therapies. Dyne Therapeutics offers its services in the United States.
Market Data
Price
$19.78
+2.09 (+11.81%)
Market Cap$2.92B
P/E Ratio—
EPS$—
52W High$25.00
52W Low$6.36
Beta1.33
Data from Finnhub · Updated Mar 11, 2026